World Thyroid Cancer Treatment Drug Market Research Report (～2027)
Global Market for Thyroid Cancer Treatment Drugs (up to 2027): Cabozantinib-S-Malate, Caprelsa, Cometriq, Doxorubicin Hydrochloride
According to the research report by 360iResearch, the global market size for thyroid cancer treatment drugs, which was $562.82 million in 2021, is expected to grow to $620.63 million in 2022 and further expand at an average annual rate of 10.44%, reaching $1,021.64 million by 2027. This report provides a multifaceted investigation into the global market for thyroid cancer treatment drugs, including an introduction, research methodology, executive summary, market overview, market insights, analysis by drug type (Cabozantinib - S - Malate, Caprelsa, Cometriq, Doxorubicin Hydrochloride, Ipilimumab), analysis by end-user (hospitals, oncology clinics, research institutions), regional analysis (North and South America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, and others), competitive landscape, company information, and more.
- Company：マーケットリサーチセンター
- Price：Other
